TOPEKA, Kan. (WIBW) - A diagnosis of diabetes can set you up for a host of health problems and a new study targets one of them.
It's a new medication researchers think could lower the risk of heart-related deaths in people with Type 2 diabetes.
Topeka's Cotton-O'Neil Diabetes Center is among those taking part in the Elixca clinical research study. Dr. Alan Wynne says it's looking at a new diabetes medication that is a once a day, non-insulin injectable medication that lowers blood sugars, but also may reduce the incident of heart attack and stroke and premature cardiovascular death.
Wynee says it's clear people with Type 2 diabetes have a higher risk of cardiovascular events, but it's not clear whether the insulin they take to control diabetes is a reason for it. He says people with the disease tend to also have other risk factors such as high blood pressure, high cholesterol and weight issues, that also lead to heart trouble.
Wynne says controlling those other risk factors lowers the risk of cardiovascular death. The question remains, though, whether a change in medication could do even more. Already, Wynne says, study participants using this non-insulin alternative are losing weight. Whether the weight loss is the mechanism that makes this medication help the heart or some other impact it might have on the blood is something the study aims to find out.
To qualify for the study, a person must have adult onset Type 2 diabetes and have suffered a heart attack in the past six months. To learn more about it or other diabetes trial, call 785-368-0490 and ask for Cathy.